Actavis PLC (NYSE:ACT)

295.41
Delayed Data
As of Apr 24
 -2.95 / -0.99%
Today’s Change
193.00
Today|||52-Week Range
317.72
+14.76%
Year-to-Date

Today’s Trading

Previous close298.36
Today’s open298.34
Day’s range295.22 - 298.76
Volume1,983,512
Average volume (3 months)3,289,829
Market cap$120.8B
Dividend yield--
Data as of 4:01pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+25.29%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.44+0.78%
GSKGlaxoSmithKline+0.28+0.60%
BMYBristol-Myers Squibb-0.20-0.30%
SNYSanofi-0.01-0.02%
Data as of 4:02pm ET, 04/24/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$3.97
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers